Sekar Kathiresan
Founder presso VERVE THERAPEUTICS, INC.
Patrimonio netto: 8 M $ in data 31/03/2024
Profilo
Sekar Kathiresan is the founder of Maze Therapeutics, Inc. (founded in 2018) and Verve Therapeutics, Inc. (founded in 2018).
He is currently the Chief Executive Officer & Director at Verve Therapeutics, Inc. and a Director at Maze Therapeutics, Inc. (founded in 2022).
Dr. Kathiresan's current job is as an Independent Director at Relay Therapeutics, Inc. (since 2022).
He previously held positions as a Director at the Center for Genomic Medicine Massachusetts General Hospital (2016-2019), Director-Cardiovascular Disease Initiative at The Broad Institute, Inc. (2014-2019), Assistant Physician at The General Hospital Corp.
(1997-2021), and Professor at Harvard Medical School (2018-2021).
Dr. Kathiresan received his undergraduate degree from the University of Pennsylvania and his doctorate from Harvard Medical School.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
VERVE THERAPEUTICS, INC.
0.81% | 14/02/2024 | 639 833 ( 0.81% ) | 8 M $ | 31/03/2024 |
RELAY THERAPEUTICS, INC.
-.--% | 04/04/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Sekar Kathiresan
Società | Posizione | Inizio |
---|---|---|
VERVE THERAPEUTICS, INC. | Founder | 01/01/2018 |
RELAY THERAPEUTICS, INC. | Director/Board Member | 25/07/2022 |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Founder | 01/04/2022 |
Precedenti posizioni note di Sekar Kathiresan
Società | Posizione | Fine |
---|---|---|
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/08/2021 |
Harvard Medical School | Corporate Officer/Principal | 01/06/2021 |
Center for Genomic Medicine Massachusetts General Hospital | Director/Board Member | 01/06/2019 |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/06/2019 |
Formazione di Sekar Kathiresan
University of Pennsylvania | Undergraduate Degree |
Harvard Medical School | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
RELAY THERAPEUTICS, INC. | Health Technology |
VERVE THERAPEUTICS, INC. | Health Technology |
Aziende private | 4 |
---|---|
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Health Technology |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Commercial Services |
Center for Genomic Medicine Massachusetts General Hospital |
- Borsa valori
- Insiders
- Sekar Kathiresan